Kevin W H Yee
24.08.2009
The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin
Schittenhelm M, Kampa-Schittenhelm K, Yee K, Heinrich M. The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin. Cell Cycle 2009; 8:2621-30.
24.08.2009The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin
24.08.2009Cell Cycle 2009; 8:2621-30
Schittenhelm Marcus, Kampa-Schittenhelm Kerstin, Yee Kevin W H, Heinrich Michael C
Weiter
10.08.2004
Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells
Yee K, Schittenhelm M, O'Farrell A, Town A, McGreevey L, Bainbridge T, Cherrington J, Heinrich M. Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells. Blood 2004; 104:4202-9.
10.08.2004Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells
10.08.2004Blood 2004; 104:4202-9
Yee Kevin W H, Schittenhelm Marcus, O'Farrell Anne-Marie, Town Ajia R, McGreevey Laura, Bainbridge Troy, Cherrington Julie M, Heinrich Michael C
Weiter